インスリン抵抗性の起源と要因について
Andrew M F Johnson1, Jerrold M Olefsky
1Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0673, USA.
Cell
|February 19, 2013
まとめ
肥満は,代謝症候群と2型糖尿病の重要な要因であるインスリン抵抗性を引き起こす. この観点では,炎症,脂質代謝,腸内微生物群を調査しています.
科学分野:
- メタボリック障害と内分泌学.
- 胃腸内科と免疫学.
背景:
- 肥満によって引き起こされるインスリン抵抗性は,代謝症候群の主要な要因です.
- メタボリックシンドロームは2型糖尿病に先行し,世界的な糖尿病流行に寄与しています.
研究 の 目的:
- インスリン抵抗性の様々な原因に関する視点を提供すること.
- インスリン抵抗性における炎症,脂質代謝,腸内微生物群の役割を強調する.
主な方法:
- この研究は,既存の研究を合成し,視点を示しています.
- 肥満,炎症,脂質代謝,腸内微生物群の相互作用に焦点を当てています.
主要な成果:
- インスリン抵抗性の原因は異質である.
- 炎症,脂質代謝,胃腸微生物群が重要な要因である.
結論:
- インスリン抵抗性の多因子の性質を理解することは,糖尿病の流行に対処するために不可欠です.
- 炎症,脂質代謝,腸内微生物群をターゲットにすることで,治療戦略を提供することができる.
関連する概念動画
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

